Clinical trial / 2012
Caffeine did not reduce daytime sleepiness but improved motor scores in Parkinson disease.
Sixty-one patients with Parkinson disease and daytime somnolence were randomized to caffeine (up to 200 mg twice daily) or placebo for six weeks. Intention-to-treat analysis showed a nonsignificant change in Epworth Sleepiness Scale score (-1.71 points; 95% CI -3.57, 0.13). However, caffeine lowered the overall score on the Unified Parkinson's Disease Rating Scale (-4.69 points; 95% CI -7.7, -1.6) and its objective motor rating (-3.15 points; 95% CI -5.50, -0.83).
- Study type
- Randomized controlled trial
- Who was studied
- 61 patients with Parkinson disease and daytime somnolence
- What was measured
- Daytime somnolence and motor severity
THE PAPER
Caffeine for treatment of Parkinson disease: a randomized controlled trial.
Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B. Neurology, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.